The idea is to ensure drug companies do not gold-plate drugs to exorbitantly raise prices while introducing those in the market.
If it gets the USFDA nod, the sales would help to pull the company out of the red.
At the end of Dec, the government had Rs 47,273 crore in the USO fund, with annual accruals of about Rs 6,000 crore.
RBI proposes tax exemption on dividend payouts and credit for corporation tax paid in host country.
Looks at sovereign funds and Fortune 500 firms.
Many say trend could lead to concerns on manufacturing quality in Indian facilities.
Through messages via the BSNL network, the ministry plans to spread awareness among the public and ask people not to invest in suspicious companies.
National Pharmaceutical Pricing Authority names Cipla, Dr Reddy's Labs and Ranbaxy among those.
Major hospital chains such as Max Healthcare, Apollo and Fortis are going online in a big way, to extend their operations into smaller towns and cities.
Not far back, in 2010, SRL Diagnostics, promoted by former Ranbaxy promoters Malvinder and Shivinder Singh, acquired the diagnostic services business of Piramal Healthcare for Rs 600 crore (Rs 6 billion).
Department of Pharmaceuticals asks NPPA to review Eli Lilly product prices.
The Cellular Operators Association of India said it would not take any legal step on the issue, unlike what it had said earlier.
Over the past 18 months, the number of caller tune subscribers, each paying Rs 30 a month for the service, has fallen from 100 million to 55 million.
On Monday, the Appellate Board upheld the compulsory licence granted to domestic firm Natco Pharma last year, against Bayer's patented anti-cancer drug Nexavar.
The panel of representatives from various ministries and chaired by B K Singh, director, department of pharmaceuticals, has suggested the government negotiate prices of patented medicines based on reference prices of such drugs in other countries such as Britain, Canada, France, Australia and New Zealand.
While the office of the Drugs Controller General of India is still struggling to accumulate data, compensation had been paid only in 50 per cent of the clinical trial death cases so far, sources said.
Companies run till now by mostly their promoters are increasingly inducting professionals to head their teams.
Charge relates to misuse of dominant position to sell spare parts at high rates.
No ethics committee shall review and accord its approval to a clinical trial protocol without prior registration with the licensing authority, as defined in clause (b) of rule 21.
Disappointed with past experience, domestic majors even skip giving any memorandum.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances